What is Particle3D?
Particle3D is at the forefront of developing bioactive bone substitutes, leveraging innovative 3D printing technology to enhance bone healing outcomes. Their core offerings are made from fully resorbable materials, designed to provide essential structural support while actively promoting natural bone formation. The company directs its solutions towards surgeons and healthcare providers, aiming to mitigate complications often associated with traditional bone grafts and implants. Through dedicated research and strategic collaborations, Particle3D is committed to advancing bone replacement solutions for individuals facing bone defects.
How much funding has Particle3D raised?
Particle3D has raised a total of $3.1M across 1 funding round:
Other Financing Round
$3.1M
Other Financing Round (2020): $3.1M with participation from West Hill Capital LLP
Key Investors in Particle3D
West Hill Capital LLP
West Hill Capital LLP is an investment firm that participated in Particle3D's funding round. Further details on their specific investment focus are not publicly available.
What's next for Particle3D?
The recent major strategic investment, coupled with the overall enterprise-level funding context, suggests Particle3D is poised for significant scaling and market expansion. This capital infusion will likely fuel further research and development, enhance manufacturing capabilities, and broaden the company's commercial reach. Particle3D's focus on innovative 3D-printed bone substitutes indicates a strategic move towards disrupting the orthopedic and regenerative medicine markets, potentially leading to wider adoption of their advanced healing technologies.
See full Particle3D company page
